Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinaki P Banerjee

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Nature Medicine|September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Nature Medicine|January 5, 2024
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Blood Cancer Discovery|October 27, 2025
CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma ModelsPaul Lin, Sunil Acharya, Francia Reyes-Silva, et al.
Nature Immunology|November 1, 2016
RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamicsElisabeth Salzer, Deniz Cagdas, Miroslav Hons, et al.
Cell Reports|July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
The Journal of Clinical Investigation|September 1, 2020
Human NK cell deficiency as a result of biallelic mutations in MCM10Emily M Mace, Silke Paust, Matilde I Conte, et al.
The Journal of Clinical Investigation|June 1, 2023
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune responseMihnea P Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, et al.
Science (New York, N.Y.)|July 13, 2013
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndromeAlessandro Aiuti, Luca Biasco, Samantha Scaramuzza, et al.
Blood Advances|July 28, 2020
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cellsRafet Basar, May Daher, Nadima Uprety, et al.
Nature Communications|October 4, 2019
Publisher Correction: Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasisNina K Serwas, Birgit Hoeger, Rico C Ardy, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Nature Medicine|September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Nature Medicine|January 5, 2024
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Blood Cancer Discovery|October 27, 2025
CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma ModelsPaul Lin, Sunil Acharya, Francia Reyes-Silva, et al.
Nature Immunology|November 1, 2016
RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamicsElisabeth Salzer, Deniz Cagdas, Miroslav Hons, et al.
Cell Reports|July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
The Journal of Clinical Investigation|September 1, 2020
Human NK cell deficiency as a result of biallelic mutations in MCM10Emily M Mace, Silke Paust, Matilde I Conte, et al.
The Journal of Clinical Investigation|June 1, 2023
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune responseMihnea P Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, et al.
Science (New York, N.Y.)|July 13, 2013
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndromeAlessandro Aiuti, Luca Biasco, Samantha Scaramuzza, et al.
Blood Advances|July 28, 2020
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cellsRafet Basar, May Daher, Nadima Uprety, et al.
Nature Communications|October 4, 2019
Publisher Correction: Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasisNina K Serwas, Birgit Hoeger, Rico C Ardy, et al.
Pageof 6